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This review brings together and consolidates the large amount of research on acute
phase proteins (APPs) that has been undertaken in chickens. Acute phase proteins
are secreted from the liver as a result of inﬂammation or infection that can be
measured in plasma. They have been well-characterised in other farm animal
species and have been measured in a wide variety of poultry research areas. The
acceleration in chicken APP research is in response to increased interest in ways the
immune responses of the chicken can be measured and compared during infection
or environmental or nutritional changes. All APPs that have been identiﬁed and
characterised in chickens are described in the following review and their responses
during infection discussed. The APPs are tabulated with basal values and
classiﬁcation to provide a comparative and useful reference. The ways APPs can
be measured in chickens and the assays available are also described. This review
will detail the functions of the positive APPs in chickens and their behaviour during
an APR.
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Introduction
The acute phase response (APR) is an early and non-speciﬁc systemic reaction of the
innate immune system to local or systemic disturbances caused by trauma, infection,
stress, surgery, neoplasia or inﬂammation, the goal of which is re-establishment of
homeostasis and healing (Gruys et al., 2005; Cray et al., 2009; Eckersall and Bell,
2010). At the site of infection or location of tissue injury, pro-inﬂammatory cytokines
and chemokines are released (Gruys et al., 2005). Cytokines and chemokines are protein
and peptide mediators secreted by cells which play a key role in immune and
inﬂammatory responses through activation and regulation of other cells and tissues
(Wigley and Kaiser, 2003). These inﬂammatory mediators initiate and modulate the
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APR, diffusing into the extracellular ﬂuid and circulating in blood. Cytokines activate
receptors on different target cells leading to a systemic APR and resulting activation of
the hypothalamic-pituitary-adrenal axis, reduction in growth hormone secretion, and a
number of physical changes clinically characterised by pyrexia, anorexia and catabolism
of muscle cells (Gruys et al., 2005). Pro-inﬂammatory cytokines and chemokines
together with nitric oxide and glucocorticoids activate hepatocytic receptors in the
liver with resultant changes in protein synthesis and secretion. As a result within the
ﬁrst few hours of an APR, there are measureable changes in the concentration of several
plasma proteins referred to as acute phase proteins (APPs) (Gruys et al., 2005).
The plasma concentrations of pro-inﬂammatory cytokines which increase within hours
of the initiating stimulus are rapidly cleared from the circulation. Acute phase protein
plasma concentrations are detectable for longer periods and are often proportional to the
severity of the stimulus. As such APP measurements are widely used as disease
biomarkers and for prognostication in human and veterinary medicine and are
increasingly used in varied areas of research.
Acute phase proteins can increase or decrease during an APR and these are termed
positive APPs or negative APPs respectively. Albumin is the most abundant plasma
protein and represents a major negative acute APP. Due to selective loss by the renal
and gastrointestinal systems or decreased hepatic synthesis, plasma albumin
concentration decreases during an APR. In chickens, albumin concentrations decrease
to 50 - 75 % of normal concentrations (Grieninger et al., 1986; Adler et al., 2001).
Positive APPs are further classiﬁed as minor, moderate or major APPs according to the
magnitude and duration of increase during the APR. Major APPs increase 10 - 1000 fold,
moderate APPs increase 4 - 10 fold and minor APPs represent those with only slight, 2 -
3 fold increases.
Major APPs tend to increase markedly within the ﬁrst 48 hours of the triggering event
and decline rapidly due to a short half life. Moderate and minor proteins tend to increase
more slowly, peak at 2-3 days and have more prolonged duration (Eckersall and Bell,
2010). Table 1 details the chicken APPs documented to date and, using published results,
the basal levels and classiﬁcation of minor, moderate or major. As well as the liver, APPs
can also be synthesised in other tissues and organs. Although extra-hepatic expression of
APPs does not account for the origin of the majority of APPs the contribution that other
tissues make can be locally signiﬁcant and furthermore, the expression pattern of an APP
can vary between tissues.
APPs are involved in many crucial metabolic and immune pathways and have roles
that include scavenging extracellular haemoglobin, iron and free radicals and direct
antibacterial and antiviral activity. The response of APPs to various pathogenic
challenges and other disruptions in homeostasis varies between species. APP proﬁles
from both companion and farm animal species have been well documented, and in many
veterinary species these clinical parameters are used diagnostically and for understanding
the pathogenesis of important diseases (Petersen et al., 2004; Eckersall and Bell, 2010).
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Table 1 Basal levels of chicken APPs and their described behaviour during an APR.
Normal serum
APP Abbreviation concentrations Reference Classiﬁcation
Albumin Al 11.08 ± 1.34 g/L Inoue et al., 1997 Negative
20 g/L (Plasma) Hrubec et al., 2002
15 g/L (Serum) Hrubec et al., 2002
α1-acid AGP 161.8 ± 25.8 mg/L Inoue et al., 1997 Moderate
Glycoprotein 228 ± 20 mg/L Takahashi et al., 1998
Ceruloplasmin CP 30 mg/L Disilvestro and Harris, 1985 Minor/Moderate
Fibrinogen FB 0.99 (± 0.11) g/L Georgieva et al., 2010 Minor
3.379 (± 0.485) g/L Naziﬁ et al., 2010
2.8 (± 0.05) g/L Amrani et al., 1986
Fibronectin FN 0.31 (± 0.4) g/L Amrani et al., 1986 Minor
Haemopexin HX 0.15 g/L Buyse et al., 2007 Minor
Mannan MBL 0.4 - 37.8 mg/L Laursen and Nielsen, 2000 Minor
binding lectin (mean 5.8 (± 4.0)
mg/L) Over 10
weeks old
Ovotransferrin OVT 0.90 ±0.06 g/L Xie et al., 2002b Minor/Moderate
1.18 (± 0.13) g/L Rath et al., 2009
PIT54 - 0.100 (± 0.020) g/L Georgieva et al., 2010 Minor
1.2 g/L Millet et al., 2007
0.09 g/L Naziﬁ et al., 2011
0.05 g/L Naziﬁ et al., 2010
Serum SAA 0.15 ± 0.02 mg/L Alasonyalilar et al., 2006 Major
amyloid A 0.166 ±0.17 mg/L Sevimli et al., 2005
1.590 ± 0.0041 Naziﬁ et al., 2010
mg/L Naziﬁ et al., 2011
1.56 ± 0.13 mg/L
Acute phase proteins
SERUM AMYLOID A
Serum amyloid A (SAA) is a major vertebrate APP and in most species is the most
sensitive protein of the APR. In mammals SAA can be induced from resting levels by
more than 1000 fold, implying an important beneﬁcial role in host defence (Eriksen et al.,
1993; Uhlar and Whitehead, 1999). In mammals, multiple SAA genes and proteins which
are strongly induced during an APR have been described (Uhlar and Whitehead, 1999;
Upragarin et al., 2005). In contrast only one SAA gene has been identiﬁed in the chicken
genome (Ovelgönne et al., 2001).
Modulating lipoprotein transport and metabolism during an APR is a major function of
SAA. This is because it allows cholesterol to remain in damaged tissues where it is
needed for repair and regeneration of membranes and to transport cholesterol and clear
lipid debris from bacteria and damaged areas of tissue (Eriksen et al., 1993; Landman,
1998). During an APR, SAA prevents oxidative tissue damage and can recruit immune
cells to localised areas of inﬂammation (Uhlar and Whitehead, 1999). SAA is
immunomodulatory, inhibiting pyrexia and down regulating pro-inﬂammatory events
during an APR (Shainkin-Kestenbaum et al., 1991; Uhlar and Whitehead, 1999). In
both mammals and birds, persistently elevated serum SAA levels, together with
ongoing inﬂammatory and/or infectious disease may result in the formation of AA
amyloid protein. The accumulation of this proteinaceous SAA derivative in organs
and tissues gives rise to the disease AA amyloidosis (Röcken and Shakespeare, 2002).
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AA amyloidosis in chickens and other Galliform species was rare until Landman et al.
(1994) reported a new syndrome of avian amyloidosis in a ﬂock of heavy breed, brown
layer hens. Birds showed signs consistent with chronic arthritis, with inﬂammatory
lesions in the joints and tendon sheaths. These lesions were found to be amyloid
giving rise to a new arthropathic classiﬁcation of amyloidosis in birds, of which
Galliformes are predisposed (Landman, 1998). Serum amyloid A, when investigated
in amyloidotic birds was found to be signiﬁcantly higher than in healthy controls
(Alasonyalilar et al., 2006).
Naziﬁ et al. (2010; 2011) found signiﬁcant increases in SAA in chickens infected with
infectious bursal disease virus (IBDV) and infectious bronchitis (IB) virus. These studies
show only mild, one and a half to two fold increases in plasma SAA concentration in
response to the viral infections. Earlier work by Upragarin (2005) found SAA increased
as a result of turpentine and Staphylococcus aureus injection with SAA levels increasing
from undetectable levels pre-injection to increases of 100-1000 fold 12 hours post
injection. At 72 hours post injection the mean SAA concentration of injected birds
was 77.23 mg/L. Alasonyalilar et al. (2006) found severely amyloidotic birds to have
mean serum SAA concentration of 42.53 mg/l. However, in this latter study the control
birds had serum concentrations of 8.48 mg/l, much higher than control levels reported in
Naziﬁ et al. (2010; 2011) and Upragarin (2005). The study by Upragarin (2005) is the
only one to use an ELISA utilising speciﬁc chicken SAA antibody, the others use a
Murine antibody. Further work is required to develop a chicken speciﬁc antibody assay to
allow further study to determine the effects of bacterial and viral infections of SAA
concentrations in chickens.
Α1-ACID GLYCOPROTEIN
α1-acid glycoprotein (AGP) is a highly glycosylated protein synthesised and secreted
by hepatocytes (Murata et al., 2004; Ceron et al., 2005). Like albumin, α1-acid
glycoprotein is an important binding protein in plasma and a natural anti-
inﬂammatory agent. It may help with the clearance of lipopolysaccharide (LPS), by
binding directly with LPS and neutralising its toxicity (Murata et al., 2004). α1-acid
glycoprotein, a moderate APP in most mammals, appears to have a signiﬁcant role in the
early stages of inﬂammation and infection in chickens.
A number of studies have investigated AGP in chickens in response to both bacterial
and viral infection. Following a single Escherichia coli LPS injection AGP plasma
concentrations increased signiﬁcantly 12 hours post injection with serum levels
increasing four-fold to peak 24 hours post injection (Takahashi et al., 1998).
Nakamura et al. (1998) found infections with E. coli LPS resulted in an increase in
AGP that peaked 48 hours post infection with a return to normal levels over 7 to 14 days.
Repeated injections of E. coli LPS was found to lower the responses of plasma AGP
concentrations (Takahashi et al., 1995) while repeated injections of LPS at different
concentrations resulted in different AGP proﬁles, with the higher concentration of
LPS giving higher AGP values (Takahashi et al., 1998). Age and sex do not
signiﬁcantly alter AGP concentrations (Takahashi et al., 1995). Adler et al. (2001),
using Salmonella typhimurium LPS and turpentine to illicit an APR found AGP levels
increased four-fold, peaking 24 hours post infection before returning to normal levels six
days post infection.
A number of studies have investigated AGP during viral infections both with and
without vaccination. Experimental infection with infectious bronchitis (IB) and infectious
larygotracheitis virus (ILTV) increased AGP serum concentrations, with AGP higher in
the IB than the ILTV infected birds (Nakamura et al., 1996). Inoue et al. (1997) found
signiﬁcant increases in serum AGP as a result of infection with a highly virulent
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infectious bursal disease virus (IBDV) strain and a virulent IBDV reference strain. The
highly virulent strain increased AGP concentrations six fold and the virulent reference
strain three fold. The chickens infected with the highly virulent strains also had extensive
lesions in addition to the severe bursal lesions. Chickens receiving the attenuated vaccine
strain of IBDV showed only a slight increase in AGP and did not develop any lesions in
the bursa or liver (Inoue et al., 1997). Chickens challenged with low pathogenic avian
inﬂuenza (LPAI) showed increases in AGP up to 48 post infection; however those that
received LPAI vaccine were shown to have signiﬁcantly lower AGP concentrations than
unvaccinated controls (Sylte and Suarez, 2012).
AGP is a highly glycosylated APP, and several AGP glycoforms may be present
normally in plasma. The glycosylation degree of AGP may be dramatically modiﬁed
during disease (Ceciliani and Pocacqua, 2007). To study the glycan composition of AGP
lectins, proteins that bind to speciﬁc carbohydrate groups can be used. The degree of
branching of AGP can be studied by means of the interaction with the lectin concanavalin
A (con A), that binds to α-linked mannose residues, two mannose molecules being
required to interact with the lectin (Ceciliani and Pocacqua, 2007). Inoue et al. (1997)
investigated the reactivity of AGP to con A in chickens experimentally infected with
infectious bursal disease virus (IBDV). In control chickens of the total AGP, 47% was
con A un-reactive and 63% con A reactive AGP. Inoculating birds with the highly
virulent IBVD strain, saw con A reactive AGP increase to 80% of total AGP in the
early stages of infection and infection with LPS increased con A to 87% of the total AGP
(Inoue, et al., 1997). The biological effects of AGP are dependent upon its glycosylation,
with con-A un-reactive AGP exhibiting a stronger inhibitory effect of lymphocyte
proliferation than the Con-A reactive. In addition, the inhibitory effects of AGP on
neutrophil superoxide anion generation depends on the glycan structure with con A
un-reactive being less inhibitory that the con A reactive (Inoue et al., 1997).
Although very little research has been undertaken on the glycosylation of chicken
AGP it is clear from this work that the glycosylation pattern was modiﬁed as a result
of IBDV.
α1-acid glycoprotein is one of the most widely measured APPs in chickens owing to
the commercial availability of easy to use and chicken speciﬁc AGP kits (ECOS Institute,
Miayagi, Japan). As a result AGP measurement has been used in a wide variety of
poultry research areas most notably in the area of nutrition where experimental diets are
followed by an immunogen challenge usually in the form of a bacterial LPS and the AGP
concentration determined. The changes in AGP concentrations as a result of nutritional
changes have been particularly well documented by Takahashi et al. (1995; 2002; 2009)
(Table 2)
The use of APPs as a physiological marker for overall health and welfare is another
potential use of APP measurement. In comparing different egg laying systems Salamano
et al. (2010) compared the serum concentrations of AGP and albumin. Mean AGP serum
concentrations, when measured at two weeks and two months post arrival at
accommodation, were higher in hens kept in conventional and modiﬁed cages than
hens in a free range system. However after four months the free range hens had
higher mean AGP than both modiﬁed and conventionally caged groups, with the
mean AGP of the free range hens having increased signiﬁcantly from two months
previously. AGP was used to evaluate stress and immunity of organically produced
broilers compared to traditionally produced broilers. The organic broilers had serum
AGP concentrations that were signiﬁcantly higher (P=<0.001) than the conventionally
produced broilers, this was attributed to restriction of prophylactic medicines coupled
with access to the outside (Tuyttens et al., 2008)..
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Table 2 Studies of bacterial, viral, parasitic, immune-mediated and metabolic diseases in chickens that
have measured acute phase proteins.
Infectious agent APP Reference
Viral Infectious bursal disease virus CP Naziﬁ et al., 2010
SAA Naziﬁ et al., 2010
PIT54 Naziﬁ et al., 2010
FB Naziﬁ et al., 2010
OVT Xie et al., 2002b
MBL Nielsen et al., 1998a; 1999
Infectious bronchitis virus SAA Naziﬁ et al., 2011
OVT Xie et al., 2002b
AGP Nakamura et al., 1996
MBL Juul-Madsen et al., 2003; 2007
Respiratory enteric orphan virus OVT Xie et al., 2002b
Fowl Poxvirus OVT Xie et al., 2002b
Infectious laryngotracheitis virus OVT Xie et al., 2002b
AGP Nakamura et al., 1996
MBL Nielsen et al., 1998b; 1999
Low pathogenic avian inﬂuenza AGP Sylte and Suarez, 2012
OVT Sylte and Suarez, 2012
Bacterial Escherichia coli (LPS) CP Butler et al., 1972
Takahashi et al., 2009
OVT Xie et al., 2002b
Hallquist and Klasing, 1994
AGP Takahashi et al., 1994; 1995; 2009
Nakamura et al., 1998
Buyse et al., 2007
HX Barnes et al., 2002
Buyse et al., 2007
CRP Patterson and Mora 1964; 1965
Salmonella ser Typhimurium (LPS) CP Song et al., 2009
Koh et al., 1996
OVT Xie et al., 2000
HX Adler et al., 2001
PIT54 Millet et al., 2007
MBL Millet et al., 2007
Salmonella ser Gallinarum Cp Garcia et al., 2009
PIT54 Garcia et al., 2009
OVT Garcia et al., 2009
HX Garcia et al., 2009
Staphylococcus aureus SAA Chamanza et al., 1999a
Upragarin, 2005
CRP Patterson and Mora, 1964
Pasteurella multocida MBL Schou et al., 2010
CRP Patterson and Mora, 1964
Parasitic Eimeria tenella CP Georgieva et al., 2010
PIT54 Georgieva et al., 2010
FB Georgieva et al., 2010
OVT Rath et al., 2009
CP Richards and Augustine, 1988
Eimeria maxima OVT Rath et al., 2009
Eimeria acervulina CP Richards and Augustine, 1988
Histomoniasis CRP Patterson and Mora, 1964
Immune Autoimmune vitiligo OVT Rath et al., 2009
mediated
Metabolic Tibial dyschondroplasia OVT Rath et al., 2009
Pulmonary hypertension OVT Rath et al., 2009
Femoral head separation OVT Durairaj et al., 2009
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OVOTRANSFERRIN
The transferrins are a family of metal binding transport proteins with an in vivo
preference for binding ferric iron (Aguilera et al., 2003). Mammals have serum
transferrin, synthesised in the liver and lactoferrin a major milk protein, synthesised in
the mammary gland. Chickens have neither of these proteins, instead synthesising
ovotransferrin (OVT) in the liver in response to proinﬂammatory cytokines and in the
oviduct under the inﬂuence of oestrogen (Hallquist and Klasing, 1994). Historically the
word conalbumin was used to describe both the egg and serum transferrin in chickens.
Williams (1968) as well as advocating ovotransferrin (OVT) as a more informative
name to describe the egg protein, demonstrated that both serum and egg OVT were the
same protein differing only in their glycosylation. More recently serum transferrin has
adopted the ‘ovo-‘ and the word ovotransferrin is frequently used to describe both egg
and serum transferrin in chickens. OVT is a positive APP in chickens (Hallquist and
Klasing, 1994; Xie et al., 2002a) with a number of studies conﬁrming that serum OVT
increases during an APR due to a variety of experimentally induced infections and
inﬂammatory processes (Table 2). This differs from mammals where serum transferrin
is a negative APP with expression being down regulated during inﬂammation (Ceron et
al., 2005). Egg OVT responds in a negative fashion during an APR, with the oviduct
magnum decreasing mRNA synthesis for egg OVT with a resultant cessation to egg
laying (Hallquist and Klasing, 1994).
Serum OVT like other members of the transferrin family is an antibacterial protein,
able to sequester, store and transport iron. Sequestering iron deprives bacteria of the iron
essential for growth (Xie et al., 2002b). A direct action on the Gram negative bacteria E.
coli has been identiﬁed as OVT is able to permeate the outer membrane causing
bacteriostasis (Aguilera et al., 2003). OVT has immunomodulatory effects inducing
respiratory burst activity and degranulation in heterophils and macrophages, and
facilitates tissue remodelling and angiogenesis, aiding post inﬂammatory repair of
tissues (Xie et al., 2002c). Xie et al. (2002b) investigated the serum OVT levels in
response to a number of viruses and E. coli (Table 3). Rath et al. (2009) compared
changes in the serum OVT concentration due to infectious diseases, metabolic diseases
and autoimmune disease. Infectious diseases showed the biggest elevation, increasing
OVT up to four fold. Autoimmune vitiligo resulted in an increase in serum OVT though
the birds with tibial dyschondroplasia, pulmonary hypertension syndrome and femoral
head separation disorder did not show elevations in serum OVT (Durairaj et al., 2009;
Rath et al., 2009). It was postulated from these results that as well as inﬂammation or
infection, tissue injury was needed to evoke a rise in OVT (Rath et al., 2009). It appears
that increases in OVT are only evident with pathogenic challenge and the increases seen
in birds with the autoimmune disorder was most likely due to the pathologically high
levels of proinﬂammatory cytokines that are stimulatory to OVT synthesis. In
investigating the response of APPs to LPAI vaccination and infection, Sylte and
Suarez (2012) also measured OVT alongside AGP and found that chickens receiving
a LPAI vaccine had signiﬁcantly lower serum OVT at 48 and 96 hours post infection than
those chickens that did not receive the vaccine.
CERULOPLASMIN
Ceruloplasmin (CP) is a vertebrate plasma protein and contains over 95% of copper
found in the plasma (Martínez-Subiela et al., 2007). Avian blood is very low in copper
compared to mammals and has lower serum levels of CP (Disilvestro and Harris, 1985).
Ceruloplasmin is a multifunctional protein both storing and transporting copper within
the body. Ceruloplasmin donates copper in a regulatory fashion with evidence of CP
receptors on the membranes of numerous different cell types, supporting CP's role as a
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cell signalling multifunctional enzyme within many different metabolic pathways (Floris
et al., 2000). Ceruloplasmin is an antioxidant protein, scavenging reactive oxygen species
and preventing their formation through its involvement in iron homeostasis. Historically,
preventing iron-induced oxidative stress has been considered to be the principle role of
the protein in vivo (Floris et al., 2000).
Butler et al. (1972) ﬁrst described CP as an APP in chickens when it was noted that a
single injection of endotoxin from E. coli increased serum CP levels by two to ﬁve fold,
the increase varying with the strain of E. coli used. The maximal increase in CP levels
was 24 hours post injection with levels still detectable 48 hours after injection. Further
studies conﬁrmed CP as a positive acute phase reactant. Salmonella gallinarum delivered
into the crop of chickens showed CP to increase the quickest of all the APPs measured in
this study, with peak serum CP levels measured three to ﬁve days post infection (Garcia
et al., 2009). Serum CP will increase signiﬁcantly in response to Eimeria tenella infection
(Richards and Augustine, 1988; Georgieva et al., 2010) and combined E. coli and E.
tenella infection (Georgieva et al., 2010). Infection of Eimeria acervulina did not
signiﬁcantly increase CP concentrations (Richards and Augustine, 1988). Naziﬁ et al.
(2010) found CP to decrease in chickens infected IBDV and the decrease was even more
pronounced in the most severely infected. It would be valuable to establish whether CP
shows a negative APP response in other viral infections in chickens or if this is an IBDV
associated response.
FIBRINOGEN
Fibrinogen (FB) is a soluble glycoprotein present in the plasma of all vertebrates
(Ceron et al., 2005). Synthesised by hepatocytes, FB functions as a key regulator of
inﬂammation during disease. The pro-inﬂammatory functions of FB, ﬁbrin and derivative
peptides are associated with their ability to bind to and activate a wide range of immune
cells. Importantly the pro-inﬂammatory functions of FB are a product of FB signalling
through binding sites that do not overlap with those involved in the coagulation cascade
(Davalos and Akassoglou, 2012). During an APR the vascular disruption associated with
pathological events such as inﬂammation, infection and tissue injury cause the
concentration of ﬁbrinogen in the blood to increase (Davalos and Akassoglou, 2012).
As well as providing a substrate for ﬁbrin formation FB also provides a matrix for the
migration of inﬂammatory related cells and for tissue repair (Murata et al., 2004).
FB is an established APP in chickens, increasing two to two and a half fold as a result
of turpentine injection, with levels peaking two to three days post injection and returning
to normal values by seven days (Amrani et al., 1986; Grieninger et al., 1986). Georgieva
et al. (2010) found FB levels increased signiﬁcantly (P=<0.001) in response to combined
infection of E. coli and E. tenella and with a single infection of E. coli or E. tenella, with
serum concentrations increasing fourfold with the E. coli infection. FB when studied
during IBDV infection was not shown to increase signiﬁcantly (Naziﬁ et al., 2010).
FIBRONECTIN
Fibronectin (FN) is large a molecular weight glycoprotein synthesised in hepatocytes as
a soluble plasma FN and in tissues as an insoluble structural form of FN, synthesised in
ﬁbroblasts, epithelial cells and other differentiated cell types (Labat-Robert, 2012). FN is
widely expressed in multiple cell types and is critically important in vertebrate
development (Pankov and Yamada, 2002). In tissues FN is an extracellular matrix
(ECM) glycoprotein playing an important role in the assembly and organisation of the
matrix and mediating a wide variety of cellular interactions. Within the matrix FN has a
wide variety of functional activities including cell adhesion, migration, growth and
differentiation. FN is able to bind biologically important molecules having binding
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sites for bacteria, collagen, ﬁbrin, FN itself and heparin (Pankov and Yamada, 2002;
Labat-Robert, 2012). Plasma FN is a minor APP, increasing during an APR and able to
diffuse into tissues and form part of the ﬁbrillar matrix (Labat-Robert, 2012) where,
together with tissue FN, it plays an important and active role in wound healing.
In chickens, Amrani et al. (1986) found plasma FN levels increased two and a half fold
as a result of turpentine injection, rapidly peaking two days post injection and remaining
elevated 52 hours after the injection. To investigate the effect of increased temperature on
FN concentration, broilers were exposed to an elevated temperature (42°C) for three
hours; 28 hours after exposure FN concentration was signiﬁcantly higher (JianHua et al.,
2000). In response to ACTH and dexamethasone administration, FN in chicken plasma
increased 1.6 and 2.5 fold respectively from basal levels and remained elevated for 52
hours (LiCheng et al., 2000).
Haem binding proteins
Under certain pathological conditions such as infection the red blood cell membrane can
destabilise resulting in the lyses of the cell and leakage of haemoglobin into circulation
(Wicher and Fries, 2006). Haemoglobin outside the cell is toxic, proinﬂammatory and
pro-oxidative causing damage to cells and tissues and haem associated iron will support
microbial growth (Ceron et al., 2005; Wicher and Fries, 2010). Plasma proteins have
therefore evolved that bind free haemoglobin and haem and mediate their removal from
the circulation (Wicher and Fries, 2010).
PIT54
Haptoglobin is the major haemoglobin binding protein found in mammals. The
haemoglobin binding protein in chickens was considered to be haptoglobin or a
haptoglobin-like protein until detailed analysis of this protein in chickens and the
chicken genome found there to be no gene coding a protein similar to mammalian
haptoglobin. Instead the protein referred to as PIT54 was identiﬁed, which fulﬁls a
similar role in chickens as haptoglobin does in mammals (Iwasaki et al., 2001;
Wicher and Fries, 2006). PIT54 is found only in avian species having been identiﬁed
in geese, ostriches and emus. Although absent in chickens, haptoglobin is found in
paleognathus birds (ostriches and emus) where haptoglobin has been conserved
alongside PIT54 (Wicher and Fries, 2010).
Haptoglobin is an anti-inﬂammatory protein, it modulates prostaglandin synthesis and
inhibits granulocyte chemotaxis and phagocytosis (Ceron et al., 2005). PIT54 evolved
from an anti-inﬂammatory protein which evolved haemoglobin binding ability (Wicher
and Fries, 2010) and it is likely that PIT54, like haptoglobin retains these anti-
inﬂammatory properties. PIT54 has been shown to have potent antioxidant properties,
inhibiting superoxide production by phagocytes, thus inhibiting the overproduction of
reactive oxygen species (Iwasaki et al., 2001) that cause oxidative damage. PIT54 is
antibacterial as binding free haemoglobin renders it unavailable for bacterial growth.
Haemoglobin iron availability and the susceptibility to infection are intimately linked
with pathological iron overload predisposing to bacterial infection (Ascenzi et al., 2005).
Naziﬁ et al. (2010; 2011) found that chickens had no signiﬁcant increase in PIT54
during IBDV infection, yet had a signiﬁcant increase as a result of IB infection. As a
result of parenteral administration of S. typhimurium LPS, mean PIT54 serum
concentrations signiﬁcantly increased 1.5 fold (Millet et al., 2007). Garcia et al.
(2009) found that intra-crop inoculation of S. gallinarum increased PIT54 throughout
the course of a 10 day infection. Georgieva et al. (2010) compared serum PIT54 after
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experimental infection with E. coli, E. tenella and combined infection of both pathogens.
The increase in PIT54 was highly signiﬁcant as a result of E. coli infection and combined
infection however serum PIT54 levels did not increase signiﬁcantly as a result of E.
tenella infection alone.
HAEMOPEXIN
Haemopexin (HX) is a haem binding protein and an established APP in chickens
(Grieninger et al., 1986; Adler et al., 2001). HX binds to the non-protein pyrrole
rings within the haem molecule. Its predominant function is to sequester and transport
haem, though it is a multifunctional protein having involvement in iron homeostasis,
antioxidant production and signalling pathways that promote cell survival and gene
expression (Tolosano et al., 2010). Barnes et al. (2002), using E. coli LPS to induce
an APR found a 2.6 fold increase in HX. Adler et al. (2001) used S. typhimurium LPS
and complete Freund's adjuvant and found HX levels to increase three fold at 24 hours
post infection, HX levels were still signiﬁcantly higher than the control birds 14 days
after the LPS challenge. Garcia et al. (2009) found HX to increase by approximately one
and a half fold in response to intra crop S. gallinarum, with serum concentration
decreasing from seven days post infection. Mammalian plasma HX declines between
24-72 hours post challenge. Establishing the behaviour of HX in response to different
infections over a period longer than 14 days would allow HX behaviour during an APR
to be fully characterised in chickens.
C-reactive protein
Originally named for its ability to bind C-polysaccharide of Pneumococcus, pneumonia,
C-reactive protein (CRP) was the ﬁrst described APP (Abernethy and Avery, 1941) and
has been deﬁned in humans as a highly sensitive marker of inﬂammation and tissue
damage. CRP is a major APP in humans and dogs and is the most frequently measured
APP in veterinary species (Eckersall and Bell, 2010). CRP binds directly to degenerating
cells and cell remnants acts as an opsonin binding residues and polysaccharides on
bacteria, fungi and parasites to activate complement and phagocytosis. CRP can also
up regulate and down regulate cytokine production and chemotaxis (Gruys et al., 2005;
Cray et al., 2009).
Patterson and Mora (1964) puriﬁed CRP from chicken serum and developed an assay
to detect the presence or absence of CRP in chicken serum. They found CRP to be
present in birds with E. coli, Pasturella multocida and Staphylococcus aureus infections,
as well as histomoniasis and adjuvant injection. The authors also found CRP positive
birds in a clinically normal population. These positive birds, on post mortem, had lesions
consistent with chronic respiratory disease, highlighting the use of CRP as a potential
biomarker for non-clinical disease. Whether CRP is a major APP in chickens as it is in
humans and other veterinary species is yet to be established. Patterson and Mora (1965)
found that CRP did not rise in chickens as quickly as it does in humans, whereby CRP
was detectable 36-48 hours post infection in chickens, compared to 16 -18 hours in
humans. It was also noted that the CRP concentration, though not quantiﬁed, appeared
lower in chickens than in comparative human samples. A more recent study investigated
CRP serum concentrations using a human CRP kit and found CRP concentrations to
increase (Sohail et al., 2010).
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Mannan binding lectin
Mannan binding lectin (MBL) belongs to a group of proteins called collectins which have
a carbohydrate recognition domain able to bind a variety of microorganisms including
bacteria, viruses, fungi and parasites. Mannan binding lectin, upon recognition of
infectious agents, activates a number of cellular defence mechanisms including
phagocytosis, modulation of cytokines and immunoglobulin secretion. Mannan
binding lectin is also able to activate the complement system through a distinct MBL
pathway (Nielsen et al., 1999; Juul-Madsen et al., 2003; Schou et al., 2010).
In chickens, MBL behaves as an minor APP with ILTV, IBDV and IB, increasing
serum MBL two fold with peak increases seen three to seven days post infection, with a
return to normal values at six to ten days (Nielsen et al., 1998a; Nielsen et al., 1999). In
relation to bacterial infections, MBL showed a signiﬁcant two fold increase when
chickens were inoculated with S. typhimurium LPS (Millet et al., 2007). Although
classed as a minor acute phase reactant, MBL plays an active and prominent role in
the immune response. When examining the baseline serum MBL concentrations in
relation to intra-tracheal inoculation of P. multocida, Schou et al. (2010) found that
chickens had signiﬁcantly higher mean MBL concentrations prior to infection
compared to four weeks post infection, and those birds that developed a systemic
infection (as determined by P. multocida invasion of spleen) following inoculation,
had lower mean baseline MBL than those with no splenic invasion, suggesting MBL
plays a role in the chickens immune system in protecting against systemic P. multocida
infection. Immuno-histochemical staining for MBL in healthy chickens detected MBL in
the cytoplasm of a few hepatocytes and germinal centres of the caecal tonsils. In birds
infected with ILTV an intense staining for MDL was detected in the cytoplasm of all
hepatocytes and on the surface of and inside ILTV infected cells. IBDV infected birds
had intense staining for MBL in the hepatocyte cytoplasm but no staining was observed
in the follicles of the bursa of Fabricius, though MBL was present in the spleen. The
presence of MBL in infected and lymphatic tissues is indicative of an important and
active role within the immune system (Nielsen et al., 1998b). Studies have also revealed
expression of MBL to be genetically inﬂuenced. Juul-Madsen et al. (2007) selected two
lines of chickens for low and high levels of serum MBL concentration. At the sixth
generation, MBL levels were found to be signiﬁcantly higher in the high line and lower
in the low line. Furthermore, when experimentally infected with IB virus,. there was a 2.3
fold and 1.6 fold increase in MBL in the low and high lines respectively (Juul-Madsen et
al., 2007).
Measuring APPs in chickens
APPs can be measured in plasma or serum. However, in avian species, plasma is more
often used because it is easier to collect than serum and yields a larger sample volume
(Hrubec et al., 2002). Blood samples can be collected into anticoagulants such as EDTA
or heparin and then be centrifuged to separate the cells. Heparin is reported as the
preferable anticoagulant for avian species owing to its low biologic activity and lack
of interference with analyte detection (Hrubec et al., 2002). Although the effect of both
anticoagulants on plasma APP measurement has not been investigated in chickens, in
mammalian species CP values were signiﬁcantly higher with heparin than EDTA and
increases in haptoglobin concentrations have been found when measured in a heparin
sample (Ceron et al., 2005). The effect of anticoagulant choice on APP concentrations
appears to be small in mammalian species (Ceron et al., 2005) however determining the
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effect of anticoagulants on measurable APP concentrations in chickens would allow more
meaningful comparison of different studies, especially for the minor APPs, where only
two or three fold changes are detected. If measuring ﬁbrinogen or ﬁbronectin (which co-
precipitates with ﬁbrinogen, (Labat-Robert and Robert 2012) then a plasma sample is
essential as a serum sample will not contain the clotting constituents.
Samples should not be haemolysed or lipaemic as this will affect the result of APPs
measured by immunoturbidimetric assays (Ceron et al., 2005) Samples can be frozen and
stored at -20°C and APPs remain stable at this temperature for up to two months (Ceron
et al., 2005). Lower temperatures are required for longer storage. Freeze thaw cycles
should be avoided, and samples should be alliquoted if necessary.
Table 3 contains references for methods or commercial kits that have been used to
measure chicken APPs. All methods used should be validated for measuring chicken
APPs especially when using antibodies against mammalian APPs. The availability of the
AGP kit, which utilises chicken speciﬁc antibody, makes this one of the most widely
measured APPs in chickens. Many labs investigating chicken APPs develop their own
assays by raising antibody to the puriﬁed chicken APP.
Table 3 How to measure acute phase proteins in chickens.
APP Measurement
Ceruloplasmin Indirectly measured using p-phenylenediamine (PPD) oxidase
activity (Sunderman and Nomoto 1970; Martínez-Subiela et al., 2007)
Fibrinogen Heat precipitation method (Thrall et al., 2004)
Fibronectin ELISA (Lynagh et al., 2000)
OVT ELISA (Xie et al., 2002b; Rath et al., 2009)
PIT54 Commercially available kits for measuring haptoglobin are based on
the haemoglobin binding activity (Eckersall et al., 1999) are effective with
chicken PIT54
Haemopexin Rocket gel electrophoresis using a rabbit anti-chicken hemopexin
(Adler et al., 2001)
SAA Mouse SAA antibody solid phase sandwich ELISA available from Tridelta (Ireland)
(Naziﬁ et al., 2010)
MBL Sandwich ELISA (Laursen et al., 1998)
α -1- glycoprotein Speciﬁc chicken single immunodiffusion test kit available using anti-chicken
AGP antibodies of rabbit origin (ECOS Institute, Miyagi, Japan)
As well as ELISA methods, gel based methods can also be used to quantify APPs.
Garcia et al. (2009) used SDS PAGE gels with samples compared to puriﬁed APPs and
the concentration of the APP calculated using a scanning densitometer. Combined
antibody and gel methods also work very well, such as the AGP kit (Table 3) and
that used by (Adler et al., 2001) to measure HX. Commercially available kits for
measuring haptoglobin in mammals also respond to PIT54 in chickens. APPs have
been used in a number of studies of infectious diseases. Table 2 summarises the
APPs that have been measured in chickens with bacterial, viral, parasitic, immune-
mediated and metabolic diseases.
Conclusions
Chamanza et al. (1999b) produced a substantial review of APPs in the domestic fowl in
1999. At the time measuring APPs in poultry species was in its infancy, no kits were
commercially available and the number of diseases in which APPs had been studied was
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limited. Since then research into APPs in poultry species, especially the chicken, has
developed widely to include many infectious diseases as well as welfare and nutritional
studies. Since the last review many APPs have been identiﬁed in the chicken and more
detailed information about chicken APPs, their structure and how they respond during an
APR is available.
Many of the APPs still require further research either to fully determine their behaviour
in the chicken or to pave way for the development of chicken speciﬁc assays which
would expand the measurement of APPs in chickens beyond the research environments.
A small number of proteomic investigations in chickens, have harnessed two-dimensional
protein methodologies and found them to yield a high level of information on how the
plasma proteome changes in response to disease. This expanding area may give rise to
the identiﬁcation of other APPs and biomarkers of disease. Other production species have
utilised APP measurement as biomarkers for health and disease and as a selection tool for
breeding programmes. Ongoing work is continuing to elaborate on the role APPs play in
the immune system of the chicken and this will be advanced greatly by the increased
availability of assays validated for chickens and concurrent proteomic investigations.
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